Our Company

Meet the Leadership Team

Marzio Pozzuoli

Chief Executive Officer
Toronto, Canada

Phil Levy, P. Eng.

Chief Technology Officer

Toronto, Canada

Dr. Keith Thompson, MD, FCFP

Chief Medical Officer

Toronto, Canada

Dr. Naresh Vempala, Ph.D.

Director of Research
Toronto, Canada

Dr. Aileen Zhou  Ph.D., BASc

Director of Regulatory Affairs 

Toronto, Canada

Dr. Paul Zheng, Ph.D.

Chief Researcher

Toronto, Canada

Chris Lin

Chief Marketing Officer

Toronto, Canada

Chris Parkes, CPA

Chief Financial Officer

Toronto, Canada

Michael Keefe

VP of Global Sales

Toronto, Canada

Valerie Lasry

Director of Sales
(EMEA & LATAM)
Tel Aviv, Israel

Ed Ellsworth B.Sc.M.Sc.

Director of Business Development, United States
California,
       United States        

Dr. Hu Jun, PhD.

General Manager
(China Region)
Hangzhou, China

Prof. John Cockcroft

Scientific Advisor
New York, United States

Dr. Kang Lee, Ph.D.

Chief Science Officer Emeritus (2015-2021) Toronto, Canada

Company Timeline

Anura exhibited on CES Asia: 5,000+ visitors experienced Anura in 3 daysRead more 

Research papers published:

Smartphone-Based Blood Pressure Measurement Using Transdermal Optical Imaging Technology on American Heart Association’s Circulation: Cardiovascular Imaging.
Measuring Blood Pressure: from Cuff to Smartphone on SpringerLink.
3 US patents registered

Read more
30 seconds Health Check released in China:

  • Heart rate
  • Blood pressure
  • Stress
  • CVD risks
  • Demographics
  • Overall health score

Read more

Transform Your Products with Affective AI.

GET IN TOUCH

Quick Links

Technology
Research
DeepAffex™
Anura™
DFXStudio™
Updates
Company
Privacy Policy
Terms of Use
Cookie Policy
  • Twitter
  • Facebook
  • Linkedin
  • Youtube

Corporate Headquarters

NuraLogix Corporation

Toronto, Canada
250 University Avenue, Suite 209
Toronto, ON, Canada M5H 3E5

Email: info@nuralogix.ai
Phone: +1 (416) 368-6000

In the United States, this product is for Investigational Use Only. The performance characteristics of this product have not been established.

© Copyright 2022 NuraLogix™ Corporation

Regional Offices

North America
sales-na@nuralogix.ai

Latin America and EMEA (Europe, Middle East and Africa)
sales-emea@nuralogix.ai

APAC (Asia-Pacific)
sales-apac@nuralogix.ai

China (Mainland)
sales-china@nuralogix.ai

Marzio Pozzuoli

Chief Executive Officer

Marzio is an experienced and passionate technology entrepreneur with over 30 years of product development experience. Prior to NuraLogix, Marzio founded RuggedCom, a communications networking company, which he took from startup to acquisition and was named the CVCA Entrepreneur of The Year for 2013.

Phil Levy, P. Eng.

Chief Technology Officer

Phil is the CTO at NuraLogix and is a veteran leader of technology product development. He brings over 25 years of direct experience with diverse, high-performance R&D teams creating breakthrough technologies.

Dr. Thompson obtained his Doctorate, Doctor of Medicine, from the University of Western Ontario. He is Fellowship Canadian College Family Practice and Adjunct Faculty Dept Family Medicine UWO, involved in Virtual Care research. He has extensive experience and network within Medical Innovation, both academic and corporate.

Dr. Naresh Vempala, Ph.D.

Director of Research

Dr. Vempala has a Ph.D. in cognitive science minoring in AI, an M.S. in computer science from the Center for Advanced Computer Studies, University of Louisiana at Lafayette, and an M.S. in civil engineering from Mississippi State University. He has over 20 years of experience in industry and academia.

Dr. Aileen Zhou, PhD, BASc

Director of Regulatory Affairs

 

Aileen brings over a decade of experience in regulatory affairs working with innovative medical devices in domestic and global markets. Prior to joining NuraLogix, Aileen held several regulatory leadership positions, including Senior Manager, Regulatory Affairs at Centre for Commercialization of Regenerative Medicine (CCRM) and Project Manager, Regulatory Affairs at Synaptive Medical, a global medical device and technology company. In these roles, Aileen provided pivotal regulatory leadership throughout the product lifecycle and played a leading role in regulatory filings and product registrations in the U.S., Canada, EU, Australia, and other international markets. Prior to that, Aileen held several positions in scientific and regulatory affairs at Induce Biologics, an innovative tissue engineering company. During her tenure, Aileen single-handedly built up the entire regulatory asset and led several successful interactions with Health Canada and the U.S. FDA.

Aileen earned a PhD with a focus in biotechnology as an NSERC scholar and a Bachelor of Applied Science in biomedical engineering, both from the University of Toronto. She is an active member and contributing author of Regulatory Affairs Professional Society.

Dr. Paul Zheng, PhD.

Chief Researcher

Dr. Pu Zheng (Paul) is the Co-founder and Senior Researcher of NuraLogix. He holds a PhD. degree in emotional psychology and has over 8 years of experience in designing and conducting behavioural and neuroimaging psychology experiments.

Chris Lin

Chief Marketing Officer

Chris Lin joined NuraLogix in 2018 as CMO, he leads the company’s brand, product strategy, go-to-market strategy and demand generation. Chris held sales and marketing leadership positions at GE, SAP, Microsoft, IBM, Dell, and Lenovo.

Chris Parkes, CPA

Chief Financial Officer

Chris is the CFO at NuraLogix and joined the company in 2016. As a former Manager in PwC’s Emerging Company Services group, he provided mainly assurance and advisory services to early-stage technology companies.

Michael Keefe

VP of Global Sales

Michael Keefe is the Vice President, Global Sales at NuraLogix. Michael brings more than 25 years of sales, strategy and product innovation experience to NuraLogix, previously working with clients including Akzo Nobel/Organon (Merck), Johns Hopkins, US Army TATRC and MediResource to expand sales and bring new products to market.

Valerie Lasry

Director of Sales (EMEA & LATAM)

Valerie Lasry is a seasoned business leader with more than 20 years’ experience in sales and business development, contributing to the company’s ongoing expansion and global growth efforts. Before joining NuraLogix, Valerie was a senior banker with BNP Paribas, followed by VP Sales and Biz Dev positions for diverse tech companies in the Start-up Nation.

Ed Ellsworth, B.Sc., M.Sc.

Director Global Regulatory Affairs and US Business Development

Ed drives regulatory compliance around the globe and business development in the US. He has over 25 years in the medical device and life science industry with a broad knowledge base and experience in executive management, corporate business development, product development, regulatory compliance, and commercial operations with large, small and startup companies.

Dr. Hu Jun, PhD.

General Manager (China Region)

Dr. Hu is the GM of our WOFE, NuraLogix (Hangzhou) Artificial Intelligence Co., Ltd.. He holds a PhD in mechanical engineering and has over 20 years of technical, sales and management experience. Prior NuraLogix, Dr. Hu was GM of RuggedCom China.

Prof. John Cockcroft

Scientific Advisor

Professor Cockcroft is visiting Professor in the Dept of Advanced Cardiology at Columbia University Medical Center, New York where he is researching haemodynamics in patients with left ventricular assist devices (LVAD’s) in terms of the vascular complications seen in this group in order to improve their cardiovascular outcomes. He has published over 350 peer-reviewed articles in the field of hypertension and cardiovascular disease.

Dr. Kang Lee, PhD.

Chief Science Officer Emeritus (2015-2021)

Dr. Lee was one of the three Co-founders of NuraLogix. He served as Chief Science Officer from the company’s founding in 2015 until September 1st of 2021. During his time at NuraLogix Dr. Lee helped pioneer Transdermal Optical Imaging (TOI™) and its use in health and wellness applications across multiple industries. He co-authored 11 patents along with numerous scientific papers and publications on the science of TOI and its many uses for healthcare.

Dr. Lee is a professor and Tier 1 Canada Research Chair in developmental neuroscience at the University of Toronto.